The SimpleMix study with biphasic insulin aspart 30: a randomized controlled trial investigating patient-driven titration versus investigator-driven titration

References

• Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-21
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53. Erratum in: Lancet 1999;354:602
   PubMed Web of Science ®Google Scholar
• Strange P. Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes. J Diabetes Sci Technol 2007;1:540-8
   PubMedGoogle Scholar
• DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003;289:2254-64
   PubMed Web of Science ®Google Scholar
• Barag SH. Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherence. J Am Osteopath Assoc 2011;111(Suppl 5):S13-19
   PubMedGoogle Scholar
• American Diabetes Association. Standards of medical care in diabetes – 2010. Diabetes Care 2009;32(Suppl 1):S4-10
   Google Scholar
• Rodbard HW, Blonde L, Braithwaite SS, et al. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):1-68
   PubMedGoogle Scholar
• International Diabetes Federation Clinical Guidelines Task Force. Global guideline for type 2 diabetes. 2012. Available at: http://www.idf.org/global-guideline-type-2-diabetes-2012 [Last accessed 9 September 2013]
   Google Scholar
• Duncan I, Ahmed T, Li QE, et al. Assessing the value of the diabetes educator. Diabetes Educ 2011;37:638-57
   PubMed Web of Science ®Google Scholar
• Novo Nordisk A/S. NovoLog Mix 30/70 prescribing information. 2013. Available at: http://www.novo-pi.com/novologmix7030.pdf [Last accessed 9 September 2013]
   Google Scholar
• Rolla A. Insulin analog mixes in the management of type 2 diabetes mellitus. Pract Diabetology 2002;21:36-43
   Google Scholar
• Ligthelm RJ. Self-titration of biphasic insulin aspart 30/70 improves glycaemic control and allows easy intensification in a Dutch clinical practice. Prim Care Diabetes 2009;3:97-102
   PubMedGoogle Scholar
• Novo Nordisk A/S. EU SmPC for insulin NovoMix 30. 2011. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Product_Information/human/000308/WC500029441.pdf [Last accessed 9 September 2013]
   Google Scholar
• Brod, M, Christensen, T, Bushnell, D. Maximising the Value of Validation Findings to Better Understand Treatment Satisfaction Issues for Diabetes. Qual Life Res 2007;16:1053-63
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonisation. ICH Harmonised Tripartite Guideline. Statistical Principles for Clinical Trials. 5 February 1998. Available at: http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html [Last accessed 15 September 2014]
   Google Scholar
• FDA. Guidance for Industry: Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention. Draft guidance. 2008. Available at: http://www.fda.gov/downloads/Drugs/guidancecomplianceregulatoryinformation/guidances/ucm071624.pdf [Last accessed 9 September 2013]
   Google Scholar
• Davies M, Storms F, Shutler S, et al. Improvement of glycemic control in patients with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005;28:1282-8
   PubMed Web of Science ®Google Scholar
• Meneghini L, Koenen C, Weng W, et al. The usage of a simplified selftitration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes – results of the randomized, controlled PREDICTIVE 303 study. Diabetes Obes Metab 2007;9:902-13
   PubMed Web of Science ®Google Scholar
• Kennedy L, Herman WH, Strange P, et al. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 2006;29:1-8
   PubMed Web of Science ®Google Scholar
• Khunti K, Davies MJ, Kalra S. Self-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care. Diabetes Obes Metab 2013;15:690-700
   PubMed Web of Science ®Google Scholar
• The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-9
   PubMed Web of Science ®Google Scholar
• Oyer DS, Shepherd MD, Coulter FC, et al. A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial). Am J Med 2009;122:1043-9
   PubMed Web of Science ®Google Scholar
• Cavanaugh K, Huizinga MM, Wallston KA, et al. Association of numeracy and diabetes control. Ann Intern Med 2008;148:737-46
   PubMed Web of Science ®Google Scholar
• Rothman R, Malone R, Bryant B, et al. Health literacy and diabetic control. JAMA 2002;288:2687-8
   PubMed Web of Science ®Google Scholar
• Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA 2002;288:475-82
   PubMed Web of Science ®Google Scholar
• Arthur SA, Geiser HR, Arriola KR, et al. Health literacy and control in the medical encounter: a mixed-methods analysis. J Natl Med Assoc 2009;101:677-83
   PubMed Web of Science ®Google Scholar
• Peyrot M, Barnett AH, Meneghini LF, et al. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med 2012;29:682-9
   PubMed Web of Science ®Google Scholar
• Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract 2008;62:860-8
   PubMed Web of Science ®Google Scholar
• Riddle MC. The underuse of insulin therapy in North America. Diabetes Metab Res Rev 2002;18(Suppl 3):S42-9
   PubMedGoogle Scholar
• Heller S, Chapman J, McCloud J, et al. Unreliability of reports of hypoglycaemia by diabetic patients. BMJ 1995;310:440
   PubMed Web of Science ®Google Scholar